BEN vs COLL
Franklin Resources Inc (BEN) versus Collegium Pharmaceutical Inc (COLL) — a side-by-side from cached financials, not a winner call.
Franklin Resources Inc (BEN) is a asset management company listed on US.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported BEN revenue for 2025-09-30 was $8.77B. Net income was $548.9M. BEN currently screens at market cap $13.09B and trailing P/E 35.6.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
BEN currently screens at market cap $13.09B and trailing P/E 35.6. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Not investment advice. Open the BEN and COLL stock pages for the full models.
Not investment advice.